These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7708722)

  • 1. Benzodiazepine receptors mediate regional blood flow changes in the living human brain.
    Matthew E; Andreason P; Pettigrew K; Carson RE; Herscovitch P; Cohen R; King C; Johanson CE; Greenblatt DJ; Paul SM
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2775-9. PubMed ID: 7708722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lorazepam [7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one] occupancy of rat brain gamma-aminobutyric acid(A) receptors measured using in vivo [3H]flumazenil (8-fluoro 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester) binding and [11C]flumazenil micro-positron emission tomography.
    Atack JR; Scott-Stevens P; Beech JS; Fryer TD; Hughes JL; Cleij MC; Baron JC; Clark JC; Hargreaves RJ; Aigbirhio FI
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1030-7. PubMed ID: 17164474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.
    Cameron OG; Huang GC; Nichols T; Koeppe RA; Minoshima S; Rose D; Frey KA
    Arch Gen Psychiatry; 2007 Jul; 64(7):793-800. PubMed ID: 17606813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of 3-(4-acetamido)-butyrril-lorazepam (DDS2700) on brain function assessed by PET at rest and during attentive tasks.
    Moresco RM; Tettamanti M; Gobbo C; Del Sole A; Ravasi L; Messa C; Paulesu E; Lucignani G; Perani D; Fazio F
    Nucl Med Commun; 2001 Apr; 22(4):399-404. PubMed ID: 11338050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the benzodiazepine antagonist flumazenil on regional cerebral blood flow in human volunteers.
    Wolf J; Friberg L; Jensen J; Hansen PB; Andersen AR; Lassen NA
    Acta Anaesthesiol Scand; 1990 Nov; 34(8):628-31. PubMed ID: 2125793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased cerebral response to inhibitory neurotransmission in alcoholics.
    Volkow ND; Wang GJ; Hitzemann R; Fowler JS; Wolf AP; Pappas N; Biegon A; Dewey SL
    Am J Psychiatry; 1993 Mar; 150(3):417-22. PubMed ID: 8382010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of diazepam-insensitive benzodiazepine receptors in the suppression of DOI-induced head-twitch responses in diabetic mice.
    Miyata S; Hirano S; Kamei J
    Psychopharmacology (Berl); 2006 May; 186(1):1-6. PubMed ID: 16555059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient increase in the in vivo binding of the benzodiazepine antagonist [3H]flumazenil in deafferented visual areas of the adult mouse brain.
    Madar I; Scheffel U; Frost JJ
    Synapse; 1994 Oct; 18(2):79-85. PubMed ID: 7839315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of flumazenil on the regional cerebral blood flow measured by [15O]-butanol PET scan and transcranial Doppler ultrasonography].
    Munkácsy C; Clemens B; Ménes A; Mikecz P; Trón L; Sikula J; Kollár J; Emri M
    Orv Hetil; 2002 May; 143(21 Suppl 3):1327-30. PubMed ID: 12077931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.
    Holthoff VA; Koeppe RA; Frey KA; Penney JB; Markel DS; Kuhl DE; Young AB
    Ann Neurol; 1993 Jul; 34(1):76-81. PubMed ID: 8390806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with flumazenil enhances binding sites for convulsants at recombinant alpha(1)beta(2)gamma(2S) GABA(A) receptors.
    Pericić D; Lazić J; Strac DS
    Biomed Pharmacother; 2005 Aug; 59(7):408-14. PubMed ID: 16084060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes.
    Ator NA; Atack JR; Hargreaves RJ; Burns HD; Dawson GR
    J Pharmacol Exp Ther; 2010 Jan; 332(1):4-16. PubMed ID: 19789360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.
    Malizia AL; Cunningham VJ; Bell CJ; Liddle PF; Jones T; Nutt DJ
    Arch Gen Psychiatry; 1998 Aug; 55(8):715-20. PubMed ID: 9707382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with [11C]alprazolam: an agonist for the benzodiazepine receptor.
    Dobbs FR; Banks W; Fleishaker JC; Valentine AD; Kinsey BM; Franceschini MP; Digenis GA; Tewson TJ
    Nucl Med Biol; 1995 May; 22(4):459-66. PubMed ID: 7550022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midazolam and other benzodiazepines.
    Olkkola KT; Ahonen J
    Handb Exp Pharmacol; 2008; (182):335-60. PubMed ID: 18175099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepine-GABAA receptor binding during absence seizures.
    Prevett MC; Lammertsma AA; Brooks DJ; Cunningham VJ; Fish DR; Duncan JS
    Epilepsia; 1995 Jun; 36(6):592-9. PubMed ID: 7555973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A late-appearing benzodiazepine-induced hypoactivity that is not reversed by a receptor antagonist.
    Lister RG; File SE
    Psychopharmacology (Berl); 1986; 88(4):520-4. PubMed ID: 3010363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent enhancement of in vivo GABA(A)-benzodiazepine receptor binding by isoflurane.
    Gyulai FE; Mintun MA; Firestone LL
    Anesthesiology; 2001 Sep; 95(3):585-93. PubMed ID: 11575528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral blood perfusion after treatment with zolpidem and flumazenil in the baboon.
    Clauss RP; Dormehl IC; Kilian E; Louw WK; Nel WH; Oliver DW
    Arzneimittelforschung; 2002; 52(10):740-4. PubMed ID: 12442636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
    Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.